🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, single-arm, multicentre, global, phase II study desi...
Status
Completed
Location
Research Site
Start Date
2014-04-30
Trial ID
NCT02127710
Treatments Being Tested
Volitinib is a potent and selective small molecule c-Met kinase inhibitor. ...
Status
Completed
Location
Samsung Medical center
Start Date
2016-02-10
Trial ID
NCT02449551
Treatments Being Tested
Clinical study to investigate the efficacy and safety of savolitinib in com...
Status
Active Not Recruiting
Location
Research Site
Start Date
2022-08-03
Trial ID
NCT05261399
Treatments Being Tested
For patients who failed primary chemotherapy with MET amplification, The ef...
Status
Recruiting
Location
Samsung Medical Center
Start Date
2023-01-05
Trial ID
NCT05620628
Treatments Being Tested
The Sponsor is developing the test medicine, AZD6094 (Savolitinib) for the ...
Status
Completed
Location
Research Site
Start Date
2020-11-13
Trial ID
NCT04675021
This is a randomized, placebo-controlled, double-blind, 3-way crossover pha...
Status
Completed
Location
Research Site
Start Date
2017-09-06
Trial ID
NCT03258515
Treatments Being Tested
This study (the SAVANNAH study) will investigate the efficacy of osimertini...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-01-09
Trial ID
NCT03778229
Treatments Being Tested
This phase II trial studies how well cabozantinib s-malate, crizotinib, sav...
Status
Completed
Location
Anchorage Associates in Radiation Medicine
Start Date
2016-07-25
Trial ID
NCT02761057
This is a single-center, randomized, open lebal, single-dose, three-period,...
Status
Completed
Location
Shanghai Xuhui District Central Hospital
Start Date
2019-04-16
Trial ID
NCT03860948
Treatments Being Tested
This study is designed for patients diagnosed with MET-driven, unresectable...
Status
Active Not Recruiting
Location
Research Site
Start Date
2017-07-25
Trial ID
NCT03091192
Treatments Being Tested